Srinivas, Sandy
Mohamed, Ateesha F.
Appukkuttan, Sreevalsa
Botteman, Marc
Ng, Xinyi
Joshi, Namita
Horodniceanu, Erica
Waldeck, A. Reginald
Simmons, Stacey J
Funding for this research was provided by:
Bayer US LLC (NA)
Article History
Received: 4 October 2019
Accepted: 20 May 2020
First Online: 22 June 2020
Ethics approval and consent to participate
: The protocol and study materials were reviewed and approved by the Salus Institutional Review Board (IRB) (protocol number 20228). All respondents in the qualitative interviews provided written informed consent prior to participating in the interviews. All respondents in the survey provided electronic agreement after reviewing the informed consent form electronically.
: Not Applicable.
: This study was funded by Bayer US LLC. SSrinivas consulted for Bayer US LLC and Janssen, and have received research funding from Bayer and Pfizer. AFM and ARW are full-time employees of Bayer US LLC and own stocks in Bayer. S Simmons is a full-time employee of Bayer US LLC and own stocks in Bayer and Pfizer. SA is a full-time employee of Bayer US LLC. MB is a shareholder of Pharmerit International, the institution which received funding from Bayer US LLC, for conducting the study. MB, XN, NJ and EH are full-time employees of Pharmerit International, the institution which received funding from Bayer US LLC, for conducting the study.